| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $389K | — | — |
| Cost of Revenue | $17K | — | — |
| R&D Expense | $29K | — | -53.0% |
| SG&A Expense | $1.7M | — | +66.4% |
| Operating Income | -$1.3M | — | -23.3% |
| Pre-tax Income | $4.3M | — | +1004.6% |
| Income Tax | $0 | — | — |
| Net Income | $4.3M | — | +1004.6% |
| EPS (Basic) | $0.45 | — | +275.0% |
| EPS (Diluted) | $0.43 | — | +975.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.6M | -33.7% | -75.4% |
| Current Assets | $30.2M | +19.2% | +97.4% |
| Total Assets | $31.0M | +20.2% | +102.5% |
| Current Liabilities | $1.1M | -39.1% | +423.9% |
| Total Liabilities | $4.9M | +24.0% | -45.0% |
| Stockholders' Equity | $23.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.7M | — | +15.9% |
| Financing Cash Flow | -$169K | — | +79.4% |
| +350.0% |